TEVA Teva Pharmaceutical Industries Limited
39.18USD+0.13%Mkt Cap: 45.70B $P/E: 65.301d ago
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers gen…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.23BUSDP/E 25.7
$58.68BUSD
GALD
Galderma Group AG$43.27BUSDP/E 56.1
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG$34.93BUSDP/E 60.5
HLN
Haleon plc$32.73BUSDP/E 19.0
$28.56BUSDP/E 12.2
$29.57BUSDP/E 11.8
$23.38BUSDP/E 19.5
$20.09BUSD
$14.43BUSDP/E 112.9
$14.58BUSDP/E 21.0
$12.99BUSDP/E 23.5
$11.17BUSD
$10.22BUSDP/E 27.9
$8.66BUSDP/E 19.3
$6.95BUSDP/E 109.1
$6.89BUSD
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S$6.51BUSDP/E 11.5
Key Statistics
Company
Market Cap45.70B USD
Enterprise Value58.84B USD
Revenue (TTM)17.32B USD
Gross Profit8.94B USD
Net Income (TTM)1.41B USD
Revenue/Share15.00 USD
Last Price39.18 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees31.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)65.30
P/E (Forward)12.69
PEG0.71
EV/EBITDA13.79
EV/Revenue3.40
P/S2.64
P/B5.88
EPS (TTM)0.60
EPS (Forward)3.08
52W Range
18.8393% of range40.79
52W High40.79 USD
52W Low18.83 USD
Profitability
Gross Margin51.79%
Oper. Margin4.03%
EBITDA Margin24.65%
Profit Margin8.17%
ROE17.83%
ROA3.46%
Growth
Revenue Growth-0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.65B USD
CapEx (TTM)501.00M USD
FCF Margin12.82%
FCF Yield4.86%
Net Debt13.24B USD
Net Debt/EBITDA3.10
Balance Sheet
Debt/Equity2.16
Current Ratio0.88
Quick Ratio0.46
Book Value/Sh6.65 USD
Cash/Share3.14 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield1.79%
Payout Ratio0.00%
Ex-Div DateNov 28, 2017
Pay DateDec 12, 2017
Splits
Last Split2:1
Split DateJul 1, 2004
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.30 USD
Upside (mean)+15.6%
Target Range40.00 USD – 55.00 USD
40.00+15.6% to mean55.00
# Analysts10
Ownership
Shares Out.1.17B
Float1.09B
Insiders0.56%
Institutions25.54%
Short Interest
Short Ratio57.4d
Short % Float2.71%
Short % Out.2.70%
Shares Short31.48M
Technical
SMA 5037.10 (+5.6%)
SMA 20033.73 (+16.2%)
Beta0.82
S&P 52W Chg15.78%
Avg Vol (30d)5.05M
Avg Vol (10d)5.40M
Technical Indicators
RSI (14)54.7
MACD0.6475
MACD Signal0.7813
MACD Hist.-0.1338
BB Upper40.88 USD
BB Middle39.06 USD
BB Lower37.24 USD
BB Width9.34%
ATR (14)1.120 USD
Vol Ratio (20d)0.65x